Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05146089 · ClinicalTrials.gov registry record · Early Phase 1
Reflex Responses to Intermittent Hypoxia in Humans: Mechanisms and Consequences
A Early Phase 1 study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 54
- Enrollment target
NCT05146089 is a Early Phase 1 study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 54 participants.
The verdict
NCT05146089, a Early Phase 1 study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 54 participants
- Enrollment target
Study Summary
The overall goal of this project is to better understand the effect of intermittent hypoxia (IH) on sympathetic neuronal discharge patterns in humans, as well as mechanisms that mediate persistent sympathoexcitation with IH.
Interventions
- OTHER Hypoxic exposure
- OTHER modified Oxford test
- DRUG Oral Bosentan 62.5 mg
- OTHER Hypoxic ventilatory response test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2016-12-20 |
| Est. Completion | 2021-04-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05146089
The ClinicalTrials.gov registry entry for NCT05146089 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Hypoxic exposure is the first listed.
NCT05146089 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05146089 about?
NCT05146089 is a clinical study titled "Reflex Responses to Intermittent Hypoxia in Humans: Mechanisms and Consequences". The overall goal of this project is to better understand the effect of intermittent hypoxia (IH) on sympathetic neuronal discharge patterns in humans, as well as mechanisms that mediate persistent sympathoexcitation with IH.
What is the current status of trial NCT05146089?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 54 participants. The study started on 2016-12-20. Estimated completion is 2021-04-12.
What interventions are being tested in trial NCT05146089?
The interventions under investigation include: Hypoxic exposure (OTHER), modified Oxford test (OTHER), Oral Bosentan 62.5 mg (DRUG), Hypoxic ventilatory response test (OTHER).
Who is sponsoring clinical trial NCT05146089?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.